Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tandem Diabetes Care (TNDM) Non-cash Items (2013 - 2018)

Tandem Diabetes Care posted quarterly Non-cash Items of $117.0 million for Q4 2018, up 19312.39% year-on-year from N/an in Q4 2017, and up 19312.39% on a QoQ basis from $602646.0 in Q4 2017.

Tandem Diabetes Care (TNDM) has 6 years of Non-cash Items data on file, last reported at $117.0 million in Q4 2018.

  • For the quarter ending Q4 2018, Non-cash Items rose 19312.39% year-over-year to $117.0 million; the trailing twelve-month figure through Dec 2018 stood at $117.0 million (up 19312.39% YoY), and the FY2018 full-year result was $117.0 million, up 19312.39% from the prior year.
  • Non-cash Items for Q4 2018 stood at $117.0 million, up from $602646.0 in the prior quarter.
  • Across five years, Non-cash Items topped out at $117.0 million in Q4 2018 and bottomed at $602646.0 in Q4 2017.
  • The 5-year median for Non-cash Items is $19.2 million (2015), against an average of $32.4 million.
  • The widest annual swing landed in 2016, when Non-cash Items tumbled 91.68%; it then jumped 19312.39% in 2018.
  • A 5-year view of Non-cash Items shows it stood at $23.5 million in 2014, then dropped by 18.59% to $19.2 million in 2015, then sank by 91.68% to $1.6 million in 2016, then sank by 62.17% to $602646.0 in 2017, then surged by 19312.39% to $117.0 million in 2018.
  • The last three Non-cash Items figures came in at $117.0 million (Q4 2018), $602646.0 (Q4 2017), and $1.6 million (Q4 2016), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Tandem Diabetes Care 1.31 Bn 739.55 Mn 136.79 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2018 116.99 Mn
Dec 31, 2018 116.99 Mn
Dec 31, 2017 602,646.00
Dec 31, 2017 602,646.00
Dec 31, 2016 1.59 Mn
Dec 31, 2016 1.59 Mn
Dec 31, 2015 19.16 Mn
Dec 31, 2015 19.16 Mn
Dec 31, 2014 23.53 Mn
Dec 31, 2014 23.53 Mn
Dec 31, 2013 80.37 Mn
Dec 31, 2013 80.37 Mn